---
figid: PMC4186798__nihms535378f6
figlink: /pmc/articles/PMC4186798/figure/F6/
number: Figure 6
caption: 'Tumors up-regulate detoxification enzymes like GSTs, which play a vital
  role in buffering the toxic effects of oxidative-stress by catalyzing the glutathione-conjugation
  of the products of lipid peroxidation like 4-HNE in the initial step of mercapturic
  acid pathway (MAP). The anticancer compound COH-SR4 inhibits the GST activity resulting
  in decreased metabolic flux. This results in increased intracellular concentration
  of toxic products of lipid peroxidation. The efflux of glutathione-conjugates by
  RLIP76 is essential for the clathrin-dependent ligand-receptor endocytosis (CDE)
  and downstream activation of signaling cascades []. AMPK forms a critical node of
  transducing oxidant and energy deficiency signals in tumors. Also, the presence
  of oncogenes like KRAS G12V in lung cancers and suppression of energy sensor proteins
  like AMPK in spite of high AMP and low ATP levels as seen in tumors, in contrast
  to normal cells where AMPK is activated when AMP levels are high, together enhance
  the rate of proliferation and survival of lung cancer cells. Hence, the ability
  of COH-SR4 to regulate the critical nodes of lung cancer signaling downstream of
  oxidative-stress and CDE like levels of pACC, pTSC2, raptor, mTOR, p70S6K along
  with regulating the expression of fibronectin, vimentin, E-cadherin and Ki67, represents
  a promising spectrum of causes for the anti-cancer effects of COH-SR4. Green arrow:
  up-regulation following COH-SR4 treatment; Red arrow: down-regulation following
  COH-SR4 treatment; Blue arrow: normal signal transduction.'
pmcid: PMC4186798
papertitle: Novel Compound 1, 3-bis (3, 5-dichlorophenyl) urea Inhibits Lung Cancer
  Progression.
reftext: Sharad S Singhal, et al. Biochem Pharmacol. ;86(12):1664-1672.
pmc_ranked_result_index: '43934'
pathway_score: 0.9672157
filename: nihms535378f6.jpg
figtitle: Novel Compound 1, 3-bis (3, 5-dichlorophenyl) urea Inhibits Lung Cancer
  Progression
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4186798__nihms535378f6.html
  '@type': Dataset
  description: 'Tumors up-regulate detoxification enzymes like GSTs, which play a
    vital role in buffering the toxic effects of oxidative-stress by catalyzing the
    glutathione-conjugation of the products of lipid peroxidation like 4-HNE in the
    initial step of mercapturic acid pathway (MAP). The anticancer compound COH-SR4
    inhibits the GST activity resulting in decreased metabolic flux. This results
    in increased intracellular concentration of toxic products of lipid peroxidation.
    The efflux of glutathione-conjugates by RLIP76 is essential for the clathrin-dependent
    ligand-receptor endocytosis (CDE) and downstream activation of signaling cascades
    []. AMPK forms a critical node of transducing oxidant and energy deficiency signals
    in tumors. Also, the presence of oncogenes like KRAS G12V in lung cancers and
    suppression of energy sensor proteins like AMPK in spite of high AMP and low ATP
    levels as seen in tumors, in contrast to normal cells where AMPK is activated
    when AMP levels are high, together enhance the rate of proliferation and survival
    of lung cancer cells. Hence, the ability of COH-SR4 to regulate the critical nodes
    of lung cancer signaling downstream of oxidative-stress and CDE like levels of
    pACC, pTSC2, raptor, mTOR, p70S6K along with regulating the expression of fibronectin,
    vimentin, E-cadherin and Ki67, represents a promising spectrum of causes for the
    anti-cancer effects of COH-SR4. Green arrow: up-regulation following COH-SR4 treatment;
    Red arrow: down-regulation following COH-SR4 treatment; Blue arrow: normal signal
    transduction.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GSTA3
  - GSTA2
  - MAP2K1
  - GSTP1
  - GSTM4
  - GSTM5
  - GSTZ1
  - GSTK1
  - GSTT2B
  - GSTA1
  - CCNA1
  - BCL2
  - GSTM3
  - CCNA2
  - GSTO2
  - MAPK3
  - GSTM1
  - GSTM2
  - MAP2K2
  - GSTA4
  - NRAS
  - GSTT2
  - MFAP1
  - BAX
  - MTOR
  - RAF1
  - GSTA5
  - MAPK1
  - ARAF
  - GSTO1
  - BRAF
  - CDH1
  - KRAS
  - HRAS
  - CDK4
  - ELAVL1
  - glucose
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTA3
  entrez: '2940'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTA2
  entrez: '2939'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTP1
  entrez: '2950'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTM4
  entrez: '2948'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTM5
  entrez: '2949'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTZ1
  entrez: '2954'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTK1
  entrez: '373156'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTT2B
  entrez: '653689'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTA1
  entrez: '2938'
- word: CyclinA
  symbol: Cyclin_A
  source: bioentities_symbol
  hgnc_symbol: CCNA1
  entrez: '8900'
- word: Bcl2,
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTM3
  entrez: '2947'
- word: CyclinA
  symbol: Cyclin_A
  source: bioentities_symbol
  hgnc_symbol: CCNA2
  entrez: '890'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTO2
  entrez: '119391'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTM1
  entrez: '2944'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTM2
  entrez: '2946'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTA4
  entrez: '2941'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTT2
  entrez: '2953'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTA5
  entrez: '221357'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: GST
  symbol: GST
  source: bioentities_symbol
  hgnc_symbol: GSTO1
  entrez: '9446'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: E-Cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: CDK4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: HuR
  symbol: HuR
  source: hgnc_alias_symbol
  hgnc_symbol: ELAVL1
  entrez: '1994'
chemicals:
- word: glucose
  source: MESH
  identifier: D005947
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
